FDA Inspection 962469 — Anson C. Lam, MD
The FDA completed an inspection of Anson C. Lam, MD on March 23, 2016 in Cypress, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 23, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Cypress, CA (United States)
Additional Details
Clinical Investigator (CI)